Intelligence · Clinical Development
Pipeline search results
Programs matching “BioPharma Corp” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 13 pipeline programs matching "BioPharma Corp" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
AB-729
Arbutus Biopharma Corp
Chronic Hepatitis b
1 trial -
AB-729-203
Arbutus Biopharma Corp
Chronic HBV Infection
1 trial -
ARB-001467
Arbutus Biopharma Corp
Hepatitis B, Chronic
1 trial -
Imdusiran
Arbutus Biopharma Corp
Hepatitis B, Chronic
1 trial -
Imdusiran (AB-729)
Arbutus Biopharma Corp
Chronic Hepatitis B
1 trial -
TKM-080301
Arbutus Biopharma Corp
Hepatocellular Carcinoma
1 trial -
TKM-080301
Arbutus Biopharma Corp
Cancer
1 trial -
AB-101
Arbutus Biopharma Corp
Chronic Hepatitis b
1 trial -
AB-101-001
Arbutus Biopharma Corp
Chronic hepatitis B virus Infection
1 trial -
AB-836
Arbutus Biopharma Corp
Chronic Hepatitis
1 trial -
PRO-040201
Arbutus Biopharma Corp
Hypercholesterolemia
1 trial -
TKM-100201
Arbutus Biopharma Corp
Ebola Virus Infection
1 trial -
TKM-100802 for Injection
Arbutus Biopharma Corp
Ebola Virus Infection
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.